MATERIAL TRANSFER, OPTION AND RESEARCH LICENSE AGREEMENTTransfer, Option and Research License Agreement • October 26th, 2015 • Lightlake Therapeutics Inc. • Metal mining • New York
This Material Transfer, Option and Research License Agreement (the “Agreement”) dated as of December 1st, 2014 (the “Effective Date”), is entered into between Aegis Therapeutics, LLC (“Aegis”), having a place of business at 11770 Bernardo Plaza Court, Suite 353, San Diego, CA 92128, and Lightlake Therapeutics, Inc. (“Lightlake”), having a place of business at 96-98 Baker Street, First Floor, London, UK, W1U 6TJ.
AMENDMENT NO. 2 TO THE MATERIAL TRANSFER, OPTION AND RESEARCH LICENSE AGREEMENT EFFECTIVE AS OF DECEMBER 1, 2014License Agreement • October 26th, 2015 • Lightlake Therapeutics Inc. • Metal mining
WHEREAS, Aegis Therapeutics, LLC, (“Aegis”) and Lightlake Therapeutics Inc. (“Lightlake”) have previously entered into the Material Transfer, Option and Research License Agreement dated as of December 1, 2014, as amended on December 16, 2014 (the “Agreement”); and
